22.12.2012 Views

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

Bulletin 2010/15 - European Patent Office

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

(A61K) I.1(2)<br />

HANADA, Takeshi, Ohra-gun Gunma 370-<br />

0503, JP<br />

HOSHINO, Masato, Ohra-gun Gunma 370-<br />

0503, JP<br />

(74) Hiebl, Inge Elisabeth, et al, Kraus & Weisert<br />

<strong>Patent</strong>- und Rechtsanwälte Thomas-Wimmer-Ring<br />

<strong>15</strong>, 80539 München, DE<br />

(51) A61K 38/46 (11) 2 174 661 A1<br />

A61P 21/00 A61P 21/02<br />

A61P 25/00 A61P 25/02<br />

A61P 43/00<br />

(25) Ja (26) En<br />

(21) 08790747.3 (22) 30.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) JP 2008/061834 30.06.2008<br />

(87) WO 2009/005033 2009/02 08.01.2009<br />

(30) 29.06.2007 JP 2007173487<br />

(54) • WIRKSTOFF ZUR LINDERUNG NEUROPA-<br />

THISCH BEDINGTER FEHLFUNKTIONEN<br />

UND RHO-KINASE-AKTIVIERUNGSHEM-<br />

MER<br />

• AGENT FOR IMPROVING DYSFUNCTION<br />

DUE TO NEUROPATHY AND RHO KINASE<br />

ACTIVATION INHIBITOR<br />

• AGENT D'AMÉLIORER D'UN DYSFONC-<br />

TIONNEMENT DÛ À UNE NEUROPATHIE<br />

ET INHIBITEUR DE L'ACTIVATION DE LA<br />

RHO KINASE<br />

(71) National University Corporation Nagoya University,<br />

1, Furo-cho, Chikusa-ku, Nagoya-shi,<br />

Aichi 464-8601, JP<br />

SEIKAGAKU CORPORATION, 6-1, Marunouchi,<br />

1-chome, Chiyoda-ku Tokyo 100-0005,<br />

JP<br />

(72) KADOMATSU, Kenji, Nagoya-shi Aichi 464-<br />

8601, JP<br />

MATSUYAMA, Yukihiro, Nagoya-shi Aichi<br />

464-8601, JP<br />

TANAKA, Akiomi, Higashiyamato-shi Tokyo<br />

207-0021, JP<br />

TAKESHITA, Sawako, Higashiyamato-shi<br />

Tokyo 207-0021, JP<br />

(74) Walcher, Armin, et al, Louis, Pöhlau, Lohrentz<br />

Postfach 3055, 90014 Nürnberg, DE<br />

(51) A61K 38/48 (11) 2 174 662 A2<br />

A61P 21/00<br />

(25) En (26) En<br />

(21) 10<strong>15</strong>04<strong>15</strong>.7 (22) 31.08.2001<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(30) 04.10.2000 US 678189<br />

(54) • Verfahren zur Behandlung von Muskelstörungen<br />

• Methods for treating muscle injuries<br />

• Procédés pour traiter les blessures musculaires<br />

(71) Allergan, Inc., 2525 Dupont Drive, Irvine, CA<br />

92612, US<br />

(72) Brooks, Gregory F., Irvine, CA 92612, US<br />

Aoki, Kei Roger, Coto de Caza, CA 92679, US<br />

(74) HOFFMANN EITLE, <strong>Patent</strong>- und Rechtsanwälte<br />

Arabellastrasse 4, 81925 München, DE<br />

(62) 01966482.0 / 1 322 324<br />

(51) A61K 38/57 (11) 2 174 663 A1<br />

A61K 47/18 A61K 47/12<br />

C07K 14/81<br />

(25) En (26) En<br />

(21) 08075968.1 (22) 08.01.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(27) 08.01.2004 PCT/US2004/000233<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(30) 08.01.2003 US 438519 P<br />

13.08.2003 US 494577 P<br />

08.10.2003 US 509260 P<br />

20.10.2003 US 512090 P<br />

(54) • Stabilisierte wässrige Zusammensetzungen<br />

mit Gewebefaktor-Inhibitor (TFPI) oder<br />

Gewebefaktor-Inhibitorvariante<br />

• Stabilized aqueous compositions comprising<br />

tissue factor pathway inhibitor (TFPI) or<br />

tissue factor pathway inhibitor variant<br />

• Compositions aqueuses stabilisées renfermant<br />

un inhibiteur de la voie du facteur<br />

tissulaire (TEPI) ou des variantes du TEPI<br />

(71) Novartis Vaccines and Diagnostics, Inc.,<br />

4560 Horton Street, Emeryville, CA 94608,<br />

US<br />

(72) Chen, Bao-Lu, San Ramon, CA 94583, US<br />

(74) Hallybone, Huw George, et al, Carpmaels &<br />

Ransford 43-45 Bloomsbury Square, London<br />

WC1A 2RA, GB<br />

(62) 04700828.9 / 1 599 222<br />

A61K 39/00 → (51) C07K 14/705<br />

A61K 39/00 → (51) C12N <strong>15</strong>/11<br />

(51) A61K 39/09 (11) 2 174 664 A1<br />

A61P 31/04 C07K 16/12<br />

(25) En (26) En<br />

(21) 08166041.7 (22) 07.10.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(54) • Neue Virulenzfaktoren von Pneumokokken<br />

• New virulence factors of Streptococcus<br />

pneumoniae<br />

• Nouveaux facteurs de virulence de la<br />

pneumonie à streptocoques<br />

(71) Stichting Katholieke Universiteit, more particularly<br />

the Radboud University Nijmegen<br />

Medical Centre, Geert Grooteplein 10, 6500<br />

HB Nijmegen, NL<br />

(72) The designation of the inventor has not yet<br />

been filed<br />

(74) Hatzmann, Martin, et al, Vereenigde Johan de<br />

Wittlaan 7, 2517 JR Den Haag, NL<br />

A61K 39/095 → (51) A61K 39/39<br />

A61K 39/104 → (51) C12N <strong>15</strong>/09<br />

A61K 39/112 → (51) A61K 39/39<br />

A61K 39/12 → (51) G01N 33/53<br />

(51) A61K 39/39 (11) 2 174 665 A2<br />

A61K 39/112 A61K 39/095<br />

A61P 11/06 A61P 37/00<br />

(25) En (26) En<br />

(21) 10001123.8 (22) 22.10.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

(30) 22.10.2003 US 513614 P<br />

06.04.2004 US 559842 P<br />

(54) • Zusammensetzungen und Verfahren für<br />

das Aktivieren der angeborenen und allergischen<br />

Immunität<br />

• Compositions and methods for activating<br />

innate and allergic immunity<br />

• Compositions et méthodes pour l'activation<br />

de l'immunité innée et allergique<br />

(71) ID Biomedical Corporation of Quebec, 525<br />

Cartier Boulevard West, Laval, QC H7V 3S8,<br />

CA<br />

(72) Lowell, George H., Hampstead Quebec H3X<br />

3K4, CA<br />

223<br />

Anmeldungen<br />

Applications<br />

Demandes (<strong>15</strong>/<strong>2010</strong>) 14.04.<strong>2010</strong><br />

Burt, David S., Dollard-des-Ormeaux Quebec<br />

H9A 3K1, CA<br />

Jones, David H., Quebec H9X 3B1, CA<br />

Zimmermann, Joseph J., St. Laurent Quebec<br />

H4L 3L1, CA<br />

Rioux, Clement, Ville-de-Cap-Rouge Quebec<br />

G1Y 2X1, CA<br />

(74) Grünecker, Kinkeldey, Stockmair & Schwanhäusser<br />

Anwaltssozietät, Leopoldstrasse 4,<br />

80802 München, DE<br />

(62) 04796097.6 / 1 689 433<br />

A61K 39/395 → (51) A61K 45/00<br />

A61K 39/395 → (51) C07K 16/18<br />

A61K 39/395 → (51) C07K 16/46<br />

A61K 39/395 → (51) C12N <strong>15</strong>/09<br />

A61K 41/00 → (51) A61N 1/40<br />

(51) A61K 45/00 (11) 2 174 666 A1<br />

A61K 31/41 A61K 31/4178<br />

A61K 31/4184 A61K 31/454<br />

A61P 25/28 A61P 43/00<br />

(25) Ja (26) En<br />

(21) 08765314.3 (22) 09.06.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) JP 2008/060513 09.06.2008<br />

(87) WO 2009/001661 2009/01 31.12.2008<br />

(30) 22.06.2007 JP 2007165071<br />

(54) • MEDIZINISCHES MITTEL ZUR PRÄVEN-<br />

TION ODER BEHANDLUNG VON ALZHEI-<br />

MER-KRANKHEIT<br />

• MEDICINAL AGENT FOR PREVENTION OR<br />

TREATMENT OF ALZHEIMER'S DISEASE<br />

• AGENT MÉDICAMENTEUX POUR LA PRÉ-<br />

VENTION OU LE TRAITEMENT DE LA<br />

MALADIE D'ALZHEIMER<br />

(71) Daiichi Sankyo Company, Limited, 3-5-1,<br />

Nihonbashi Honcho, Chuo-ku Tokyo 103-<br />

8426, JP<br />

Osaka University, 1-1, Yamadaoka, Suita-shi<br />

Osaka 565-0871, JP<br />

(72) MORISHITA, Ryuichi, Suita-shi Osaka 565-<br />

0871, JP<br />

SATO, Naoyuki, Suita-shi Osaka 565-0871,<br />

JP<br />

TAKEDA, Shuko, Suita-shi Osaka 565-0871,<br />

JP<br />

(74) Wallace, Sheila Jane, et al, Marks & Clerk<br />

LLP 90 Long Acre, London WC2E 9RA, GB<br />

(51) A61K 45/00 (11) 2 174 667 A1<br />

A61K 39/395 A61P 27/02<br />

A61P 29/00<br />

(25) Ja (26) En<br />

(21) 08792022.9 (22) 25.07.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

AL BA MK RS<br />

(86) JP 2008/063809 25.07.2008<br />

(87) WO 2009/014263 2009/05 29.01.2009<br />

(30) 26.07.2007 JP 2007194269<br />

(54) • MITTEL ZUR BEHANDLUNG VON AUGEN-<br />

ENTZÜNDUNGEN MIT INTERLEUKIN-6-<br />

REZEPTORHEMMER ALS WIRKSTOFF<br />

• AGENT FOR TREATMENT OF OPHTHAL-<br />

MIA CONTAINING INTERLEUKIN-6<br />

RECEPTOR INHIBITOR AS ACTIVE<br />

INGREDIENT

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!